1. EMT-Inducing Molecular Factors in Gynecological Cancers
   Loredana Campo et al, 2015, BioMed Research International CrossRef
2. Ultrasensitive Label-Free Sensing of IL-6 Based on PASE Functionalized Carbon Nanotube Micro-Arrays with RNA-Aptamers as Molecular Recognition Elements
   Farhad Khosravi et al, 2017, Biosensors CrossRef
3. Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells
   Xiaoxiao Lu et al, 2016 CrossRef
4. EMT in cervical cancer: its role in tumour progression and response to therapy.
   Rehana Qureshi et al, 2015, Cancer Lett CrossRef
5. Ancient cancers and infection-induced oncogenesis
   Paul W. Ewald, 2017, International Journal of Paleopathology CrossRef
6. Radiolabeling and preliminary biodistribution study of 99m Tc-labeled antibody-mimetic scaffold protein repebody for initial clearance properties
   Sajid Mushtaq et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
7. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition
   Ming Liu et al, 2017, Anat. Rec. CrossRef
8. Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
   Pengju Wang et al, 2017, Nat Commun CrossRef
9. Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment
   Qian Liu et al, 2017, Tumour Biol. CrossRef
10. Carcinosarcoma of the Parotid
    Anneliese Vélez-Pérez et al, 2015, Int J Surg Pathol CrossRef
11. In vitro effects of Staphylococcus aureus enterotoxin C3 on T cell activation, proliferation and cytokine production
    Yixin Xie et al, 2017 CrossRef
12. Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells
    Yebo Gao et al, 2017 CrossRef
13. NF-κB, inflammation, immunity and cancer: coming of age.
    Koji Taniguchi et al, 2018, Nat Rev Immunol CrossRef
14. Mechanisms and Αpplications of Ιnterleukins in Cancer Immunotherapy
    Doxakis Anestakis et al, 2015, IJMS CrossRef
15. Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549
    Masashi Kawami et al, 2018, Biochemical and Biophysical Research Communications CrossRef
16. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells
    Dongdong Sun et al, 2018, Biomedicine & Pharmacotherapy CrossRef
17. Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer
    Travis M. Bettison et al, 2018, Pancreas CrossRef
18. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?
    Sang-Heum Park et al, 2018, Korean J Pancreas Biliary Tract CrossRef
19. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial–mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway
    Zhengguang Zhang et al, 2018, Inflammopharmacol CrossRef
20. Epithelial-Mesenchymal Transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids
    Chang Hoon Lee, 2018, Biochemical Pharmacology CrossRef
21. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
    Yilin Che et al, 2019, Cancer Lett CrossRef
22. Controlling metastatic cancer: the role of phytochemicals in cell signaling.
    Andrea Kapinova et al, 2019, J Cancer Res Clin Oncol CrossRef
23. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
    Elisabetta Romeo et al, 2019, Cells CrossRef
24. Fighting Thyroid Cancer with Microgravity Research
    Marcus Krüger et al, 2019, IJMS CrossRef
25. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    José Esparza-López et al, 2019, BMC Cancer CrossRef
26. Astrocyte Elevated Gene-1 Promotes Progression of Cervical Squamous Cell Carcinoma by Inducing Epithelial-Mesenchymal Transition via Wnt Signaling
    Enlin Song et al, 2015, International Journal of Gynecological Cancer CrossRef
27. Kaempferia parviflora Extract Inhibits STAT3 Activation and Interleukin-6 Production in HeLa Cervical Cancer Cells
    Benjamart Suradej et al, 2019, IJMS CrossRef
28. Biological Response Modifier in Cancer Immunotherapy
    Ronghua Liu et al, 2016 CrossRef
29. Alteration of early dendritic cell activation by cancer cell lines predisposes immunosuppression, which cannot be reversed by TLR4 stimulation
    Ying Ying Kong et al, 2016, Acta Biochim Biophys Sin CrossRef
30. Antitumor Activity ofPortulaca OleraceaL. Polysaccharide on HeLa Cells Through Inducing TLR4/NF-κB Signaling
    Rui Zhao et al, 2017, Nutrition and Cancer CrossRef
31. Pharmacological and immunological targeting of tumor mesenchymalization
    Justin M. David et al, 2017, Pharmacology & Therapeutics CrossRef
32. Potential Anti-proliferative and Immunomodulatory Effects of Marine Microalgal Exopolysaccharide on Various Human Cancer Cells and Lymphocytes In Vitro
    Geon-Tae Park et al, 2017, Mar Biotechnol CrossRef
33. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
    Paola Ortiz-Montero et al, 2017, Cell Commun Signal CrossRef
34. EMT and inflammation: inseparable actors of cancer progression.
    Meggy Suarez-Carmona et al, 2017, Mol Oncol CrossRef
35. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring
    Sugandha Bhatia et al, 2017 CrossRef
36. RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis—an updated review
    Fatéméh Dubois et al, 2019, Cell Death Dis CrossRef
37. The Anti-Proliferative Activity of the Hybrid TMS-TMF-4f Compound Against Human Cervical Cancer Involves Apoptosis Mediated by STAT3 Inactivation
    Joo Young Hong et al, 2019, Cancers CrossRef
38. Combined Snail and E-cadherin Predicts Overall Survival of Cervical Carcinoma Patients: Comparison Among Various Epithelial-Mesenchymal Transition Proteins.
    Yuejun Tian et al, 2020, Front Mol Biosci CrossRef
39. New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression
    Sugandha Bhatia et al, 2020, Front. Mol. Biosci. CrossRef
40. Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes
    Yan Liu et al, 2020 CrossRef
41. MicroRNAs in cancer metastasis and angiogenesis.
    Weiyang Lou et al, 0 CrossRef
42. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3
    Zhongyi Fan et al, 2015, Oncotarget CrossRef
43. Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions
    Jing Bai et al, 2015, Oncotarget CrossRef
44. Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells
    Wei-Hsiu Liu et al, 2015, Oncotarget CrossRef
45. Senescent Cells in Cancer Therapy: Friends or Foes?
    Boshi Wang et al, 2020, Trends Cancer CrossRef
46. Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial–Mesenchymal Transition
    Karina Martins-Cardoso et al, 2020, Cancers CrossRef
47. Positive Feedback Loop of SNAIL-IL-6 Mediates Myofibroblastic Differentiation Activity in Precancerous Oral Submucous Fibrosis
    Chih-Yu Peng et al, 2020, Cancers CrossRef
48. Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
    Weijuan Yan et al, 2018, Oncol Lett CrossRef
49. Affective disorders as risk predictor of developing cancer on example of malignant tumors of pancreas
    A. V. Pavlovsky et al, 2020, Medicinskij alfavit CrossRef
50. Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy
    Silvina Odete Bustos et al, 2020, Front. Oncol. CrossRef
51. EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas
    Camille Lachat et al, 2020, Cancers CrossRef
52. LncRNA LINC00518 Acts as an Oncogene in Uveal Melanoma by Regulating an RNA-Based Network
    Cristina Barbagallo et al, 2020, Cancers CrossRef
53. Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment
    Shuo Wang et al, 2021, Cancers CrossRef
54. Exosomal miR-128-3p Promotes Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells by Targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling.
    Jian Bai et al, 2021, Front Cell Dev Biol CrossRef
55. Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk
    Md. Harun-Or-Roshid et al, 2021, PLoS ONE CrossRef
56. Senescent cells in cancer therapy: why and how to remove them
    Jian-Wei Zhang et al, 2021, Cancer Letters CrossRef
57. Tumor Microenvironment: Involved Factors and Signaling Pathways in Epithelial-Mesenchymal Transition
    Madeh Ghaderi et al, 2021, Int J Cancer Manag CrossRef
58. The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression.
    Andrea Abaurrea et al, 2021, Int J Mol Sci CrossRef
59. Partial EMT in head and neck cancer biology: a spectrum instead of a switch
    Ananya Pal et al, 2021, Oncogene CrossRef
60. Dynamic EMT: a multi‐tool for tumor progression
    Simone Brabletz et al, 2021, EMBO J CrossRef
61. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
    Giovanni Barillari et al, 2021, IJMS CrossRef
62. STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
    Sarah Q. To et al, 2022, Cancers CrossRef
63. Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells
    Abhilasha Srivastava et al, 2022, Front. Oncol. CrossRef
64. Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
    Rosamaria Lappano et al, 2022, Cancers CrossRef
65. Antineoplastic action of sulforaphane on HeLa cells by modulation of signaling pathways and epigenetic pathways
    Madhumitha KEDHARI SUNDARAM et al, 2022, Minerva Med CrossRef
66. MiR-99a-5p Constrains Epithelial–Mesenchymal Transition of Cervical Squamous Cell Carcinoma Via Targeting CDC25A/IL6
    Ailing Gu et al, 2022, Mol Biotechnol CrossRef
67. Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
    Wiktoria Monika Piskorz et al, 2022, IJMS CrossRef
68. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
    Aysun Özdemir et al, 2022 CrossRef
69. Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation
    Laurent Gorvel et al, 2023, Seminars in Immunology CrossRef
70. Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation
    Cynthia Clemente-González et al, 2022, Cancers CrossRef
71. Compressed Prostate Cancer Cells Decrease Osteoclast Activity While Enhancing Osteoblast Activity In Vitro
    Victor J. B. van Santen et al, 2023, IJMS CrossRef
72. The Role of Cytokines in Epithelial–Mesenchymal Transition in Gynaecological Cancers: A Systematic Review
    Irene Ray et al, 2023, Cells CrossRef
73. Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control
    Kulbhushan Thakur et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
74. Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway
    Bin Liu et al, 2023, BMC Cancer CrossRef
75. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
    Nasim Ebrahimi et al, 2024, Cancer Metastasis Rev CrossRef
76. MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer
    Alessia Maria Cossu et al, 2024, Molecular Therapy - Nucleic Acids CrossRef
77. Advances on Senescence-associated Secretory Phenotype Regulated by Circular RNAs in Tumors
    Yue Qiu et al, 2024, Ageing Research Reviews CrossRef
78. Prognostic and Therapeutic Potential of STAT3: Opportunities and Challenges in Targeting HPV-Mediated Cervical Carcinogenesis
    Divya Janjua et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
79. Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review)
    Guoan Zhang et al, 2024, Int J Oncol CrossRef
80. Senescence cell signature associated with poor prognosis, epithelial–mesenchymal transition, solid histology, and spread through air spaces in lung adenocarcinoma
    Young Wha Koh et al, 2024, GeroScience CrossRef
81. Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells
    Wiktoria Monika Piskorz et al, 2024, Molecules CrossRef
82. Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
    Hina Amer et al, 2024, Cancers CrossRef
83. Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring
    Zhen Zhang et al, 2024 CrossRef